STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIVE
  4. [Form 3] HIVE Digital Technologies Ltd. Initial Statement of Beneficial Ownership

HIVE Digital Technologies (HIVE) CFO details stock options and RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

HIVE Digital Technologies Ltd. CFO Darcy Daubaras reports existing equity awards, including options and restricted stock units tied to common stock. He holds options to buy 100,000 shares at an exercise price of $0.9700 expiring on December 21, 2028, another 100,000 shares at $1.0500 expiring on February 10, 2030, and 75,000 shares at $4.9400 expiring on July 6, 2028.

He also reports multiple blocks of restricted stock units (RSUs), such as 150,000, 205,625 and 300,000 units, each representing the right to receive one share of common stock at settlement. Footnotes state several option and RSU grants are fully vested, while some RSUs vest in 2026 and 2027. Daubaras additionally holds 8,900 shares of common stock directly.

Positive

  • None.

Negative

  • None.
Insider Daubaras Darcy
Role CFO
Type Security Shares Price Value
holding Options (right to buy) -- -- --
holding Options (right to buy) -- -- --
holding Options (right to buy) -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Restricted Stock Units -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Options (right to buy) — 100,000 shares (Direct); Restricted Stock Units — 150,000 shares (Direct); Common Stock — 8,900 shares (Direct)
Footnotes (1)
  1. These options were granted on December 21, 2018 and are fully vested as of the date hereof. Represents an exercise price of $1.35 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on February 10, 2020 and are fully vested as of the date hereof. Represents an exercise price of $1.45 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on July 6, 2023 and are fully vested as of the date hereof. Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on January 11, 2023 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024, and 93,750 have vested, with the remaining 56,250 vesting in 3 equal installments on May 5, 2026, August 5, 2026, and November 5, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.
Stock options 2018 grant 100,000 shares at $0.9700 Options to buy common stock expiring December 21, 2028; fully vested
Stock options 2020 grant 100,000 shares at $1.0500 Options to buy common stock expiring February 10, 2030; fully vested
Stock options 2023 grant 75,000 shares at $4.9400 Options to buy common stock expiring July 6, 2028; fully vested
RSU block 205,625 RSUs Each RSU represents one common share; issued July 18, 2024
Largest RSU grant 300,000 RSUs Each RSU represents one common share; issued March 16, 2026, vesting March 16, 2027
Common shares held 8,900 shares Direct holdings of HIVE common stock reported by CFO
Future RSU vesting date April 17, 2026 RSU grant issued April 17, 2025 vests in one installment on this date
Future RSU vesting date March 16, 2027 RSU grant issued March 16, 2026 vests in one installment on this date
Restricted Stock Unit financial
"Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
exercise price financial
"Represents an exercise price of $1.35 Canadian dollars, converted to U.S. dollars..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
fully vested financial
"These options were granted on December 21, 2018 and are fully vested as of the date hereof."
expiration date financial
"Options (right to buy)... expiration_date: "2028-12-21T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
settlement financial
"Each RSU represents the right to receive, at settlement, one share of common stock."
Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Daubaras Darcy
(Last)(First)(Middle)
7900 CALLAGHAN ROAD, SUITE 128
(Street)
SAN ANTONIO TEXAS 78229
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/30/2026		3. Issuer Name and Ticker or Trading Symbol
HIVE Digital Technologies Ltd. [ HIVE ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock8,900D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Options (right to buy) (1)12/21/2028Common Stock100,000$0.97(2)D
Options (right to buy) (3)02/10/2030Common Stock100,000$1.05(4)D
Options (right to buy) (5)07/06/2028Common Stock75,000$4.94(6)D
Restricted Stock Units (7) (7)Common Stock150,000$0D
Restricted Stock Units (8) (8)Common Stock205,625$0D
Restricted Stock Units (9) (9)Common Stock150,000$0D
Restricted Stock Units (10) (10)Common Stock60,000$0D
Restricted Stock Units (11) (11)Common Stock200,000$0D
Restricted Stock Units (12) (12)Common Stock200,000$0D
Restricted Stock Units (13) (13)Common Stock200,000$0D
Restricted Stock Units (14) (14)Common Stock300,000$0D
Explanation of Responses:
1. These options were granted on December 21, 2018 and are fully vested as of the date hereof.
2. Represents an exercise price of $1.35 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
3. These options were granted on February 10, 2020 and are fully vested as of the date hereof.
4. Represents an exercise price of $1.45 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
5. These options were granted on July 6, 2023 and are fully vested as of the date hereof.
6. Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026.
7. Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on January 11, 2023 and are fully vested as of the date hereof.
8. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof.
9. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024, and 93,750 have vested, with the remaining 56,250 vesting in 3 equal installments on May 5, 2026, August 5, 2026, and November 5, 2026.
10. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof.
11. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026.
12. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026.
13. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026.
14. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.
Remarks:
The Board of Directors of HIVE Digital Technologies Ltd. (the "Company") has determined that the Company no longer qualifies as a foreign private issuer. As a result, effective April 1, 2026, the Company is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934, as amended. The Reporting Person is filing this Form 3 in connection with this transition. Exhibit 24 Power of Attorney
/s/ Darcy Daubaras03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the HIVE Form 3 filing by CFO Darcy Daubaras show?

The Form 3 shows CFO Darcy Daubaras’ existing equity position in HIVE, including stock options, restricted stock units and common shares. It is an initial ownership report, not a record of recent share purchases or sales.

How many HIVE stock options does CFO Darcy Daubaras hold?

Darcy Daubaras holds options over 100,000 HIVE shares at $0.9700, 100,000 shares at $1.0500, and 75,000 shares at $4.9400. These options allow him to buy common stock at the stated exercise prices before each option’s expiration date.

What restricted stock units (RSUs) are reported for HIVE CFO Darcy Daubaras?

The filing lists several RSU blocks, including 150,000, 205,625, 150,000, 60,000, 200,000, 200,000, 200,000 and 300,000 units. Each RSU represents a right to receive one HIVE common share at settlement, with some awards already fully vested and others vesting through 2027.

Are the HIVE CFO’s stock options and RSUs vested according to the Form 3 footnotes?

Footnotes state options granted in 2018, 2020 and 2023 are fully vested. Several RSU grants from 2023 to early 2025 are also fully vested, while others will vest on specific dates in 2026 and 2027, such as April 17, 2026 and March 16, 2027.

Does the HIVE Form 3 indicate any recent share purchases or sales by the CFO?

The summarized data show only holding entries with zero buy and sell counts, indicating this Form 3 records existing holdings. It does not reflect new market purchases or sales, but rather establishes Daubaras’ baseline ownership position in HIVE securities.